Growth Metrics

Verastem (VSTM) Cash from Investing Activities Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 38.24%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 30.54%
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn -171.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -171.08%
Dec 31, 2025 -28.12%
Jun 30, 2024 129.68%
Mar 31, 2024 65.14%
Dec 31, 2023 29.20%
Sep 30, 2023 -2,168.88%
Jun 30, 2023 704.41%
Mar 31, 2023 -26.52%
Dec 31, 2022 -19.67%
Sep 30, 2022 -35.84%
Jun 30, 2022 -14.34%
Mar 31, 2022 275.79%
Dec 31, 2021 26.00%
Sep 30, 2021 38.31%
Jun 30, 2021 86.77%
Mar 31, 2021 -68.56%
Dec 31, 2020 -169.64%
Sep 30, 2020 -26.00%
Jun 30, 2020 -26.03%
Mar 31, 2020 98.53%
Dec 31, 2019 194.27%
Sep 30, 2019 67.72%
Jun 30, 2019 14.36%
Mar 31, 2019 -30.98%
Dec 31, 2018 -117.91%
Sep 30, 2018 -59.83%
Jun 30, 2018 -27.22%
Mar 31, 2018 27.93%
Dec 31, 2017 -30.58%
Sep 30, 2017 40.92%
Jun 30, 2017 -7.85%
Mar 31, 2017 -0.18%
Dec 31, 2016 -29.32%
Sep 30, 2016 27.77%
Jun 30, 2016 80.52%
Mar 31, 2016 -64.77%
Dec 31, 2015 45.88%
Sep 30, 2015 -56.02%
Jun 30, 2015 57.59%
Mar 31, 2015 0.55%
Dec 31, 2014 33.43%
Sep 30, 2014 182.94%
Jun 30, 2014 242.14%